Clinical trials
Carcinoma, Non-Small-Cell Lung trials in South Africa
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 10 |
| Active, not recruiting | 9 |
| Recruiting | 7 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 7 |
| Pfizer | 7 |
| AstraZeneca | 6 |
| Bristol-Myers Squibb | 5 |
| Hoffmann-La Roche | 4 |
| AbbVie | 3 |
| Eli Lilly and Company | 3 |
| Genzyme, a Sanofi Company | 3 |
| Boehringer Ingelheim | 2 |
| Checkpoint Therapeutics, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 66 |
| Lung Neoplasms | 18 |
| Neoplasm Metastasis | 6 |
| Carcinoma | 4 |
| Adenocarcinoma of Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Melanoma | 3 |
| Neoplasms | 3 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Carcinoma, Transitional Cell | 2 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.